Clinical trial
RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe…
NCT00497471 · Hospital Clinic of Barcelona, Other · Terminated
Key facts
| NCT number | NCT00497471 |
|---|---|
| Title | RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants |
| Official title | The Prevention of Anaemia and Malaria in Infants in an Area of Intense and Perennial Malaria Transmission |
| Lead sponsor | Hospital Clinic of Barcelona, Other |
| Collaborators | Agencia Española de Cooperación Internacional World Health Organization |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Malaria, Anemia |
| Intervention type | Drug |
| Interventions | Deltaprim (3.125 mg pyrimethamine plus 25 mg dapsone), iron (2 mg/kg/daily) |
| Enrollment | 832 |
| Start date | Feb 1, 1995 |
| Completion | Jul 1, 1999 |
| First posted | Jul 6, 2007 |
| Last update posted | Jul 6, 2007 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: